$TWSI - Sales for the first quarter of 2014 exceed overall sales for the previous year, and are trending to bring significant growth for the remainder of the year. This growth is fueled by new focus on sales and marketing efforts of HemCon's exclusive partner in Japan, Zeria Pharmaceuticals Ltd. Co. http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U